Browse Studies — Arctuva

Phase 2

Optimizing PSMA Imaging for Enhanced Detection of Residual and Metastatic Prostate Cancer in Low PSA Recurrence (OPERA) Study

This is a randomized, open-label, pilot study assessing the impact of a short course of bicalutamide on PSMA expression in patients with prostate cancer belong…

Prostate CancerRecurrent Prostate CancerMetastatic Prostate Cancer+2 more

Estimated

~$10 – $6,250

Washington University School of MedicineNCT07593079

Phase 2

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy (Fezo-ADT Trial)

The goal of this clinical trial is to learn if fezolinetant can treat hot flashes (vasomotor symptoms) in men with prostate cancer undergoing androgen deprivat…

Prostate CancerProstate Cancer (Adenocarcinoma)Prostate Cancer Metastatic Disease+16 more

Estimated

~$10 – $7,500

Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities

Prostate Cancer (PC) is the most common non-cutaneous malignancy diagnosed and second leading cause of cancer death among men across the United States. PC amon…

Prostate CancerProstate Cancer RecurrentProstate Metastases

Estimated

~$10 – $675

University of California, San FranciscoNCT07690579

Phase 1

Combination of Autophagy Selective Therapeutics (COAST) in Advanced Solid Tumors or Relapsed Prostate Cancer, A Phase I/II Trial

The purpose of this Phase I/II study is to determine the safety and effectiveness of up to 5 study drugs used together for the treatment of solid tumor cancers…

Prostate Cancer RecurrentSolid Tumor, Adult

Estimated

~$10 – $6,250

Medical University of South CarolinaNCT05036226